Literature DB >> 6498718

Hepatitis B follow-up among Indochinese refugees.

E S Nicholls, R K Chaudhary, D A Kennedy, J Jung, J W Davies, P Gill.   

Abstract

During 1979 and 1980 the Department of National Health and Welfare carried out a survey and later routine testing to determine the prevalence of serologic markers of hepatitis B in Indochinese refugees entering Canada. Between March and July 1981 the hepatitis-B-marker status of 220 selected refugees in the Ottawa-Hull area was reassessed. Overall, 173 (79%) of the participants had the same serologic markers when retested, but in 47 (21%) the markers had changed. The most significant changes were the loss of antigenemia in 22% of those who had been HBsAg-positive and the appearance of evidence of infection in 18% of those who had been seronegative. Most of these changes occurred among persons under 30 years of age, especially females aged 10 to 19 years.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6498718      PMCID: PMC1483772     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  14 in total

Review 1.  The transmission and outcome of hepatitis A, B, and non-A, non-B: a review.

Authors:  D P Francis; J E Maynard
Journal:  Epidemiol Rev       Date:  1979       Impact factor: 6.222

2.  Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan.

Authors:  R P Beasley; L Y Hwang; C C Lin; C S Chien
Journal:  Lancet       Date:  1981-11-21       Impact factor: 79.321

3.  Hepatitis B antigenemia among blood donors: the changing scene.

Authors:  B P Moore; R A Perrault
Journal:  Can Med Assoc J       Date:  1975-01-11       Impact factor: 8.262

Review 4.  Serologic markers of hepatitis B virus infection.

Authors:  J H Hoofnagle
Journal:  Annu Rev Med       Date:  1981       Impact factor: 13.739

5.  Prevalence of hepatitis B markers in Indochinese refugees.

Authors:  R K Chaudhary; E S Nicholls; D A Kennedy
Journal:  Can Med Assoc J       Date:  1981-12-01       Impact factor: 8.262

6.  A comparative study of hepatitis B viral markers in the family members of Asian and non-Asian patients with hepatitis B surface antigen-positive hepatocellular carcinoma and with chronic hepatitis B infection.

Authors:  M J Tong; J M Weiner; M W Ashcavai; A G Redeker; S Comparini; G N Vyas
Journal:  J Infect Dis       Date:  1979-10       Impact factor: 5.226

7.  Transmission of hepatitis B antigens from symptom free carrier mothers to the fetus and the infant.

Authors:  V C Wong; A K Lee; H M Ip
Journal:  Br J Obstet Gynaecol       Date:  1980-11

8.  Hepatitis B e antigen, DNA polymerase activity, and infection of household contacts with hepatitis B virus.

Authors:  R P Perrillo; L Gelb; C Campbell; W Wellinghoff; F R Ellis; L Overby; R D Aach
Journal:  Gastroenterology       Date:  1979-06       Impact factor: 22.682

9.  Host responses to hepatitis-B infection in patients with primary hepatic carcinoma and their families. A case/control study in Senegal, West Africa.

Authors:  B Larouze; G Saimot; E D Lustbader; W T London; B G Werner; M Payet
Journal:  Lancet       Date:  1976-09-11       Impact factor: 79.321

10.  The seroepidemiology of hepatitis in Papua New Guinea. II. A long-term study of hepatitis B.

Authors:  R A Hawkes; C R Boughton; V Ferguson; T G Vale
Journal:  Am J Epidemiol       Date:  1981-10       Impact factor: 4.897

View more
  3 in total

1.  The health care needs of southeast asian refugees.

Authors:  J M Morse; A J Edwards; T Kappagoda
Journal:  Can Fam Physician       Date:  1988-11       Impact factor: 3.275

2.  Prevalence study of different hepatitis markers among pregnant Albanian refugees in Greece.

Authors:  A Malamitsi-Puchner; S Papacharitonos; D Sotos; L Tzala; M Psichogiou; A Hatzakis; A Evangelopoulou; S Michalas
Journal:  Eur J Epidemiol       Date:  1996-06       Impact factor: 8.082

3.  Chronic hepatitis B infection in Canada.

Authors:  G Y Minuk; J Uhanova
Journal:  Can J Infect Dis       Date:  2001-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.